CoraLite® Plus 750 Anti-Human BCMA/TNFRSF17 Rabbit Recombinant Antibody

BCMA/TNFRSF17 Uni-rAbTM Recombinant Antibody for FC
Cat No. CL750-98215

产品说明书

CloneNo. 241731A11

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC

TNFRSF17, CD269, BCMA, BCM, B-cell maturation protein

缓冲液配方:  PBS and Azide
PBS and Azide
规格: 
25tests
100tests

¥2290/ 100tests

浓度: 5 ul/test


经过测试的应用

Positive FC detected inU266 cells
For other applications, we recommend the unconjugated version of this antibody, 98215-1-PBS

推荐稀释比

应用推荐稀释比
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

产品信息

CL750-98215 targets BCMA/TNFRSF17 in FC applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 Recombinant protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 tumor necrosis factor receptor superfamily, member 17
别名 TNFRSF17, CD269, BCMA, BCM, B-cell maturation protein
计算分子量 184 aa, 20 kDa
GenBank蛋白编号BC058291
基因名称 TNFRSF17
Gene ID (NCBI) 608
偶联类型 CoraLite® Plus 750 Fluorescent Dye
最大激发/发射波长755 nm / 780 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ02223
储存缓冲液 PBS with 0.09% sodium azide and 0.5% BSA.
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

BCMA (B cell maturation antigen), also known as TNFRSF17, is 20.2-kDa type III transmembrane glycoprotein and is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes and plasma cells, which may be important for B cell development and autoimmune response (PMID: 32943087; 9846698). BCMA has two agonist ligands: a proliferation-inducing ligand (APRIL) and BAFF. When BCMA binds to APRIL, it transmits signals of cell survival and proliferation (PMID: 27127303); when BCMA binds to BAFF, it mediates the activation of NF-kappaB and MAPK8/JNK (PMID: 36140254). It has been found that the overexpression and activation of BCMA are associated with multiple myeloma (MM) in preclinical models and humans, supporting its potential utility as a therapeutic target for MM (PMID: 32055000; 32943087).

实验方案

Product Specific Protocols
FC protocol for CL Plus 750 BCMA/TNFRSF17 antibody CL750-98215Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...